PMC:5118426 / 16089-16556 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/5118426","sourcedb":"PMC","sourceid":"5118426","source_url":"https://www.ncbi.nlm.nih.gov/pmc/5118426","text":"In humans, a recent study of cognitively intact patients identified and validated a set of blood-based biomarkers that included glycoursodeoxycholic acid (GUDCA) that could predict the onset of either AD or amnestic mild cognitive impairment, considered an early precursor of AD, within 2–3 years with an accuracy of over 90% (Mapstone et al., 2014). This suggests a potential association of bile acids in the progression or preclinical neurodegenerative phase of AD.","tracks":[{"project":"MyTest","denotations":[{"id":"27920719-24608097-31054333","span":{"begin":344,"end":348},"obj":"24608097"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"attributes":[{"subj":"27920719-24608097-31054333","pred":"source","obj":"MyTest"}]},{"project":"2_test","denotations":[{"id":"27920719-24608097-31054333","span":{"begin":344,"end":348},"obj":"24608097"}],"attributes":[{"subj":"27920719-24608097-31054333","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"MyTest","color":"#93a4ec","default":true},{"id":"2_test","color":"#beec93"}]}]}}